Small cell lung cancer and non-small cell lung cancer6t7 have a few key differences and several similarities that we will explore here.

Data from nearly 6,000 Parkinson's disease patients provides insights into who these individuals are and why clinical trial participation matters.

We share easy-to-access resources for people living with COPD, their families, and their care partners.

After analyzing a set of data from over 5,000 lupus patients, we’re sharing the insights we gained into how to better reach this population for clinical trial recruitment.

Osteoporosis impacts many Americans, but many people are unaware of what the condition is or how it is caused.

Increasing diversity in clinical trials is important for inclusion and for the accuracy of research — and in this blog, we examine how to do so.

For National Alzheimer’s Disease Awareness Month, we’re taking a look at Alzheimer’s vs. dementia to highlight the differences between the two.

As the most common type of dementia in the United States, Alzheimer's disease has an interesting history filled with medical research contributions.

The clinical trials timeline is long and consists of several phases, but this is what ensures that drugs are safe before being put on the market.

Though osteoporosis is a serious condition, there are many ways that patients can continue to live an independent and fulfilling life with the disease.

There can be many benefits to participating in medical research studies, and in this blog, we discuss the best ways to find the right fit.

Kidney disease is common, but its terminology can often be confusing. This blog examines the differences between CKD, Stage 3 kidney disease, and C3G.